Copyright
©The Author(s) 2023.
World J Exp Med. Sep 20, 2023; 13(4): 75-94
Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75
Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75
Figure 7 Protein expression of neural marker, and CD133 in the circulated neural cells from the neural system to the blood stream in a patient with Alzheimer disease.
A: Merged of phase contrast/dapi/neural marker (NE)/CD133, in which the presence of beta-Amyloid is remarkable in the background of this image; B: Merged dapi/NE/CD133, reflects the co-expression between NE and CD133; C: Diverse expression of NE, reflects the dissected of only upper section of image with low expression of NE; accompanied by an isolated section with low expression of NE; including group of cells with positive expression; D: Diverse protein function including high and low expression of CD133. The protein expression of NE/vascular endothelial growth factor/erythroblastosis virus E26 oncogene homolog 2 is also provided (Figure 8).
- Citation: Mehdipour P, Fathi N, Nosratabadi M. Personalized clinical managements through exploring circulating neural cells and electroencephalography. World J Exp Med 2023; 13(4): 75-94
- URL: https://www.wjgnet.com/2220-315X/full/v13/i4/75.htm
- DOI: https://dx.doi.org/10.5493/wjem.v13.i4.75